Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of the Computation of Basic and Diluted Net Loss Per Share of Common Stock

The following tables set forth the computation of basic and diluted net loss per share of common stock for the three months ended March 31, 2023 and March 31, 2022 (in thousands, except share and per share amounts):


	Three Months Ended
	March 31, 2023
Net loss	$	(9,955)
Weighted average shares	11,722,764
Basic and diluted net loss per share	$	(0.85)


	Three Months Ended
	March 31, 2022
Net loss	$	(22,051)
Weighted average shares	9,399,518
Basic and diluted net loss per share	$	(2.35)

Schedule of Anti-dilutive Securities Excluded From Computation of Diluted Weighted Shares Outstanding

The following outstanding securities have been excluded from the computation of diluted weighted shares outstanding for the three months ended March 31, 2023 and 2022, as they could have been anti-dilutive:


	Three Months Ended
	March 31,
	2023	2022
Stock options	1,460,346	1,424,004
Warrants on common stock1	4,136,990	367,187
Restricted Stock Units	—	938

1 The weighted average number of common shares outstanding as of March 31, 2023 and 2022 included the weighted average effect of the 114,007 pre-funded warrants outstanding because the exercise of such warrants requires only nominal consideration ($0.012 per share exercise price for each pre-funded warrant). Therefore, these pre-funded warrants are not included in the table above.